Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: charlyt who wrote (11865)	6/2/2004 9:58:48 AM
From: zeta1961	Read Replies (2) \| Respond to of 52153

Yes, Charly...quite honestly, I read conditional approval, was thrilled and read the rest of the PR quickly... It is confusing...I wonder how we can clarify this? because as you know...technically, a conditional approval allows you to market the drug as they did with Gleevec et. al and does not get full approval until it's done with the studies...ALTH had/has ENRICH in place... This needs further clarification...I don't have a handy source...do you? Thanks... Zeta